Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Launch imminent for Fujisawa's new treatment of atopic dermatitis

Nov. 22, 1999

Allergan establishes agreement with 3M for Tazorac

Nov. 22, 1999

AxyS discontinues further development of APC-2059 in psoriasis

Nov. 19, 1999

Small patient study indicates potential new indication for leflunomide

Nov. 17, 1999

FDA accepts NDA for tacrolimus ointment

Nov. 16, 1999

Chromanone derivatives for androgen-dependent and other disorders disclosed by Novartis

Nov. 16, 1999

FDA authorizes OrthoLogic to proceed with Chrysalin trials in fracture healing

Nov. 16, 1999

Candidate treatment for atopic dermatitis presented at Japanese congress

Nov. 2, 1999

PDE4-inhbitory pyridines disclosed by Janssen

Oct. 27, 1999

Polyethoxylated retinamides superior to known retinoic acid derivatives for skin aging

Oct. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.